Anitha Suram

Anitha Suram is an accomplished professional in clinical pharmacology with extensive experience spanning over a decade. Currently serving as the Director of Clinical Pharmacology at Blueprint Medicines since November 2021, Anitha has previously held positions as Associate Director and Senior Scientist in the same field within the company. Before joining Blueprint Medicines, Anitha worked as a Pharmacokineticist at Bristol Myers Squibb from May 2020 to July 2021 and spent several years in clinical research at T.A. Sciences, Inc. from 2013 until April 2020. Anitha's academic background includes a Doctor of Philosophy degree from CFTRI School in India and a Master of Science in Pharmacometrics from the University of Maryland, Baltimore, completed in 2020, following a postdoctoral fellowship at Rutgers University from 2007 to 2012.